Last reviewed · How we verify

NCT03226873

Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV

Completed NA Last updated 16 July 2018
What this trial tests

NA trial testing Peer Navigation in Pre-exposure Prophylaxis in 66 participants. Completed in 19 March 2018.

Timeline
16 November 2017
Primary endpoint
19 March 2018
19 March 2018

Quick facts

Lead sponsorMontefiore Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment66
Start date16 November 2017
Primary completion19 March 2018
Estimated completion19 March 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Montefiore Medical Center

Who can join

18 and older, any sex, with Pre-exposure Prophylaxis or HIV-1-infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study will assess the feasibility and acceptability of a peer outreach and navigation intervention designed to increase access and promote HIV pre-exposure prophylaxis (PrEP) uptake among women at high risk for HIV.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Peer Navigation

Trials testing the same drug.

Other recruiting trials for Pre-exposure Prophylaxis

Currently open trials in the same condition.

Other Montefiore Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03226873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing